Canada· CA-DIN-02496305
SUVEXX
A sumatriptan and naproxen product containing naproxen sodium + sumatriptan (sumatriptan succinate), registered in Canada by ARALEZ PHARMACEUTICALS CANADA INC. The same ATC class is registered in 8 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Sumatriptan and naproxen is registered in 8 of 19 countries.
Countries holding a registration under ATC N02CC51 (sumatriptan and naproxen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 4 of them publish a price we can compare per daily dose
Sumatriptan and naproxen · ATC N02CC51
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- NAPROXEN SODIUM + SUMATRIPTAN (SUMATRIPTAN SUCCINATE)
- Manufacturer
- ARALEZ PHARMACEUTICALS CANADA INC
- Country
- Canada (CA)
- ATC code
- N02CC51
- ATC class
- Sumatriptan and naproxen
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sumatriptan and naproxen in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesSumatriptan Succinate and Naproxen SodiumCurrax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven
- CzechiaFRIMIG DUOOrion Corporation, Espoo
- SpainSUVEXX 85 MG/500 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULAOrion Corporation
- FinlandNomigrinOrion Corporation
- FranceNOMANESIT 85 mg/500 mg comprimé pelliculéORION CORPORATION
- United KingdomSuvexx 85mg/457mg tabletsOrion Pharma (UK) Ltd
- IrelandMigsun 85 mg/500 mg film-coated tabletsOrion Corporation
- NetherlandsSuvexx 85 mg/500 mg filmomhulde tablettenOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Sumanet
- Belgium · Migsun
- Czechia · Frimig Duo
- Germany · Suvexx
- Denmark · Nomigrin
- Estonia · Migsun
- Spain · Suvexx
- Finland · Nomigrin
- France · Nomanesit
- United Kingdom (Northern Ireland) · Suvexx
- Greece · Suvexx
- Hungary · Nomigrin
- Ireland · Migsun
- Italy · Sumanet
- Lithuania · Migsun
- Latvia · Migsun
- Netherlands · Suvexx
- Norway · Nomigrin
- Poland · Frimig Duo
- Portugal · Suvexx
- Sweden · Nomigrin
- Slovakia · Frimig Duo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/50874343-7c10-4787-b6ad-b3e2c73c1b7d GET /v1/drugs/50874343-7c10-4787-b6ad-b3e2c73c1b7d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02496305",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N02CC51",
"schedule": [
"Prescription"
],
"drug_code": "98619",
"strengths": [
"500 MG",
"85 MG"
],
"ahfs_class": null,
"substances": [
"NAPROXEN SODIUM",
"SUMATRIPTAN (SUMATRIPTAN SUCCINATE)"
],
"product_categorization": null
}See everything about sumatriptan and naproxen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.